These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 32561657)

  • 41. BCG versus COVID-19?
    Kantor IN
    Medicina (B Aires); 2020; 80(3):292-294. PubMed ID: 32442946
    [No Abstract]   [Full Text] [Related]  

  • 42. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.
    Nascimento Silva JR; Camacho LA; Siqueira MM; Freire Mde S; Castro YP; Maia Mde L; Yamamura AM; Martins RM; Leal Mde L;
    Vaccine; 2011 Aug; 29(37):6327-34. PubMed ID: 21640779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.
    Ceyhan M; Kanra G; Erdem G; Kanra B
    Vaccine; 2001 Aug; 19(31):4473-8. PubMed ID: 11483273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is BCG vaccination causally related to reduced COVID-19 mortality?
    Miyasaka M
    EMBO Mol Med; 2020 Jun; 12(6):e12661. PubMed ID: 32379923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?
    Ehtesham NZ; Samal J; Ahmad F; Arish M; Naz F; Alam A; Agrawal U; Hasnain SE
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):16-20. PubMed ID: 32859863
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Carryn S; Feyssaguet M; Povey M; Di Paolo E
    Vaccine; 2019 Aug; 37(36):5323-5331. PubMed ID: 31345639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Number of doses of Measles-Mumps-Rubella vaccine applied in Brazil before and during the COVID-19 pandemic.
    da Silva TMR; de Sá ACMGN; Vieira EWR; Prates EJS; Beinner MA; Matozinhos FP
    BMC Infect Dis; 2021 Dec; 21(1):1237. PubMed ID: 34886804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [MMR vaccination at UNIL and EPFL : Lausanne medical students get involved].
    Porret R; Ishii A; Petignat C; Crisinel PA
    Rev Med Suisse; 2020 Oct; 16(710):1938-1940. PubMed ID: 33058581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reply to Özdemir, "Measles-Mumps-Rubella Vaccine and COVID-19 Relationship".
    Fidel PL; Noverr MC
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963010
    [No Abstract]   [Full Text] [Related]  

  • 50. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.
    Simon HU; Karaulov AV; Bachmann MF
    Int Arch Allergy Immunol; 2020; 181(8):624-628. PubMed ID: 32544911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
    Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
    Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
    Netea MG; Giamarellos-Bourboulis EJ; Domínguez-Andrés J; Curtis N; van Crevel R; van de Veerdonk FL; Bonten M
    Cell; 2020 May; 181(5):969-977. PubMed ID: 32437659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.
    Klein NP; Abu-Elyazeed R; Povey M; Macias Parra M; Diez-Domingo J; Ahonen A; Korhonen T; Tinoco JC; Weiner L; Marshall GS; Silas PE; Sarpong KO; Ramsey KP; Fling JA; Speicher D; Campos M; Munjal I; Peltier C; Vesikari T; Baccarini C; Caplanusi A; Gillard P; Carryn S; Henry O
    J Pediatric Infect Dis Soc; 2020 Apr; 9(2):194-201. PubMed ID: 30849175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020.
    McDonald HI; Tessier E; White JM; Woodruff M; Knowles C; Bates C; Parry J; Walker JL; Scott JA; Smeeth L; Yarwood J; Ramsay M; Edelstein M
    Euro Surveill; 2020 May; 25(19):. PubMed ID: 32431288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
    Escobar LE; Molina-Cruz A; Barillas-Mury C
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17720-17726. PubMed ID: 32647056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.
    Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM
    Front Immunol; 2019; 10():2806. PubMed ID: 31849980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
    Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A
    J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
    Lundberg L; Bygdell M; Stukat von Feilitzen G; Woxenius S; Ohlsson C; Kindblom JM; Leach S
    Vaccine; 2021 Jul; 39(32):4414-4418. PubMed ID: 34187707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.